GcMAF Australia
Senior Member
- Messages
- 1,027
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3044169/
nPTLS and CFS have distinguishing CSF protein complements. Each condition has a number of CSF proteins that can be useful in providing candidates for future validation studies and insights on the respective mechanisms of pathogenesis. Distinguishing nPTLS and CFS permits more focused study of each condition, and can lead to novel diagnostics and therapeutic interventions.
I know it is a bit hard to find out some of the information here as it is a bit of a summary. They are looking at proteins in the Pooled cerebrospinal fluid of Neurologic Post Treatment Lyme disease (nPTLS) and Chronic Fatigue (CFS.
One interesting thing is that Table S5. (Pathway analysis for proteins identified only in nPTLS proteome.)
Also a lot of these are invoved in immunity for both Lyme and CFS, for example the Complement System and Coagulation System
nPTLS and CFS have distinguishing CSF protein complements. Each condition has a number of CSF proteins that can be useful in providing candidates for future validation studies and insights on the respective mechanisms of pathogenesis. Distinguishing nPTLS and CFS permits more focused study of each condition, and can lead to novel diagnostics and therapeutic interventions.
I know it is a bit hard to find out some of the information here as it is a bit of a summary. They are looking at proteins in the Pooled cerebrospinal fluid of Neurologic Post Treatment Lyme disease (nPTLS) and Chronic Fatigue (CFS.
One interesting thing is that Table S5. (Pathway analysis for proteins identified only in nPTLS proteome.)
- indicates that the melatonin pathway is affected in Lyme people , and not in the CFS group
Also a lot of these are invoved in immunity for both Lyme and CFS, for example the Complement System and Coagulation System